NF2 and neoplasm: We identified a pathogenic heterozygous deletion of NF2 in blood DNA and the concomitant loss of the NF2 locus in the tumor through the loss of the whole chromosome 22, demonstrating that PM was driven by the bi-allelic loss of function of NF2.